Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

100%

4 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
3(75.0%)
Phase 4
1(25.0%)
4Total
Phase 3(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07445737Phase 3Not Yet Recruiting

Use of the Methoxyflurane as Pain-killer in the Prehospital Management of Acute Myocardial Infarction

Role: collaborator

NCT03215056Phase 3Completed

Methoxyflurane Analgesia for Paediatric Injuries

Role: lead

NCT01420159Phase 3Completed

Efficacy and Safety of Methoxyflurane (Penthrox) for the Treatment of Acute Pain in Minor Trauma

Role: lead

NCT00524927Phase 4Completed

Safety and Efficacy of Methoxyflurane for Treatment of Incident Pain

Role: lead

All 4 trials loaded